Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Serial Neuromelanin MRI to Assess Depigmentation Rates in the Substantia Nigra of Early Parkinson's Disease

NCT05631158 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT05631158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Serial Neuromelanin MRI to Assess Depigmentation Rates in the Substantia Nigra of Early Parkinson's Disease
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2020
Completion date
July 31, 2024
Enrollment
135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, progression, disease